“…Many of the proarrhythmic drugs block one or more of the ion channels found in the heart (K + , Na + , Ca 2+ ), making HoC systems well-suited to study their effects. Examples include verapamil (a Ca 2+ channel blocker), 168,180,182,183,360,365,366,369,[391][392][393][394] quinidine (Na + -channel blocker), 182,359,392,395 E-4031 (hERG K + -channel blocker), 180,359,360,363,[396][397][398] sotalol (K + -channel blocker), 391 nifedipine (a Ca 2+ -channel blocker), 305,361,396,397 ranolazine (Na +channel blocker), 396 flecainide (Na + -channel blocker), 362,397,398 tetrodotoxin (Na + -channel blocker), 398 ouabain (Na + /K + -ATPase blocker), 359 ATX-II (Na + -channel blocker), 359 and dofetilide (K +channel blocker). 359,395 The Lee group has developed various iterations of cantilever-based sensors to monitor real-time changes in contractile function after exposing cardiac tissue to different concentrations of drugs known to be cardiotoxic, including quinidine, E-4031, and verapamil.…”